Pulse Biosciences (PLSE) Capital Expenditures (QoQ) (2015 - 2025)
Pulse Biosciences (PLSE) Capital Expenditures (QoQ) (2015 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Pulse Biosciences | 2.09 Bn | 2.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -43.55% |
| Sep 30, 2025 | 9,400.00% |
| Jun 30, 2025 | -107.69% |
| Mar 31, 2025 | -16.13% |
| Dec 31, 2024 | 293.75% |
| Sep 30, 2024 | -200.00% |
| Dec 31, 2023 | 86.96% |
| Sep 30, 2023 | 43.75% |
| Jun 30, 2023 | -58.97% |
| Mar 31, 2023 | -4.88% |
| Dec 31, 2022 | -33.87% |
| Sep 30, 2022 | -77.12% |
| Jun 30, 2022 | 903.70% |
| Mar 31, 2022 | 109.78% |
| Dec 31, 2021 | -275.80% |
| Sep 30, 2021 | 65.26% |
| Jun 30, 2021 | 86.27% |
| Mar 31, 2021 | 117.53% |
| Dec 31, 2020 | -569.35% |
| Sep 30, 2020 | 187.32% |